跳至主要内容
临床试验/NCT01981057
NCT01981057已完成不适用

Clinical Experience With Numeta- Impact on Intake of Nutrients and Costs

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Protein

研究概览

简要总结

The aim of this prospective noninterventional study is to evaluate the clinical application of Numeta® in preterm infants and critically ill neonates in comparison to individualized prescribed parenteral nutrition. With the prescription software Cato-PAN® (by Cato software solutions) exact valid prescriptions for ordering parenteral nutrition solutions for premature infants are compared. Each PN solution is prescribed individually as well as with Numeta. Prescriptions were mirrored with respect to weight, venous approach, total volume and amount of enteral feeding, 24h medication and flipped vice versa. The key nutrient for calculating Numeta prescriptions was protein. The results of PN prescriptions were compared with each other/ESPGHAN recommendations. The investigators hypothesize that nutrimental content of Numeta prescriptions is equal to individually prescribed .parenteral nutrition solutions

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
1 Hour 至 3 Months(Child)
性别
All
接受健康志愿者

入选标准

  • preterm infants <37 weeks gestational age
  • parenteral nutrition therapy

排除标准

  • hypersensitivity to egg, soy or peanut proteins or to any of the active substances
  • congenital abnormality of the amino acid metabolism
  • pathogenically elevated plasma concentrations of sodium, potassium, magnesium, calcium and/or phosphorous
  • severe hyperglycemia
  • severe hyperlipidemia
  • severe disorders of lipid metabolism characterized by hypertriglyceridemia

结局指标

主要结局

Protein

时间窗: 6 weeks

Prescriptions for protein in parenteral nutrition solutions will be ordered individually and flipped with Numeta or "vice versa". This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations.

次要结局

  • Potassium(6 weeks)
  • Magnesium(6 weeks)
  • Fat(6 weeks)
  • Phosphorous(6 weeks)
  • Energy(6 weeks)
  • Sodium(6 weeks)
  • Osmolarity(6 weeks)
  • Carbohydrates(6 weeks)
  • Calcium(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nadja Haiden,MD

Assoc.Prof.MD

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验